{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:16Z","timestamp":1793831296739,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071827"],"award-info":[{"award-number":["82071827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03545-4","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:41:23Z","timestamp":1743849683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cluster analysis reveals three clinical phenotypes of pulmonary artery hypertension associated with connective tissue diseases: insights into inflammation and immunity"],"prefix":"10.1186","volume":"27","author":[{"given":"Qianwen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangshu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangdi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"1","key":"3545_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-024-00493-2","volume":"10","author":"A Mocumbi","year":"2024","unstructured":"Mocumbi A, Humbert M, Saxena A, et al. Publisher correction: pulmonary hypertension. Nat Rev Dis Primers. 2024;10(1):5.","journal-title":"Nat Rev Dis Primers"},{"key":"3545_CR2","doi-asserted-by":"crossref","unstructured":"Boucherat O, Agrawal V, Lawrie A, Bonnet S. The latest in animal models of pulmonary hypertension and right ventricular failure. Circ Res. 2022;130(9).","DOI":"10.1161\/CIRCRESAHA.121.319971"},{"issue":"4","key":"3545_CR3","doi-asserted-by":"crossref","first-page":"103514","DOI":"10.1016\/j.autrev.2024.103514","volume":"23","author":"E Favoino","year":"2024","unstructured":"Favoino E, Prete M, Liakouli V, et al. Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): similarities, differences and the role of autoimmunity. Autoimmun Rev. 2024;23(4):103514.","journal-title":"Autoimmun Rev"},{"key":"3545_CR4","doi-asserted-by":"crossref","unstructured":"Molano-Gonz\u00e1lez N, Rojas M, Monsalve DM et al. Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity. J Autoimmun. 2019;98.","DOI":"10.1016\/j.jaut.2018.11.002"},{"key":"3545_CR5","doi-asserted-by":"crossref","first-page":"106238","DOI":"10.1016\/j.phrs.2022.106238","volume":"180","author":"RR Wang","year":"2022","unstructured":"Wang RR, Yuan TY, Wang JM, et al. Immunity and inflammation in pulmonary arterial hypertension: from pathophysiology mechanisms to treatment perspective. Pharmacol Res. 2022;180:106238.","journal-title":"Pharmacol Res"},{"key":"3545_CR6","doi-asserted-by":"crossref","unstructured":"Kularatne M, Boucly A, Savale L et al. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension. Expert Opin Pharmacother. 2023;24(18).","DOI":"10.1080\/14656566.2023.2273395"},{"issue":"6","key":"3545_CR7","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.3390\/ijms24065085","volume":"24","author":"K Parperis","year":"2023","unstructured":"Parperis K, Velidakis N, Khattab E, Gkougkoudi E, Kadoglou NPE. Systemic lupus erythematosus and pulmonary hypertension. Int J Mol Sci. 2023;24(6):5085.","journal-title":"Int J Mol Sci"},{"key":"3545_CR8","doi-asserted-by":"crossref","unstructured":"Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181(12).","DOI":"10.1164\/rccm.200909-1331PP"},{"key":"3545_CR9","doi-asserted-by":"crossref","unstructured":"Chaisson NF, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2013;144(4).","DOI":"10.1378\/chest.12-2396"},{"key":"3545_CR10","doi-asserted-by":"crossref","unstructured":"Hassoun PM. Pulmonary Arterial Hypertension. N Engl J Med. 2021;385(25).","DOI":"10.1056\/NEJMra2000348"},{"key":"3545_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43:38.","journal-title":"Eur Heart J"},{"key":"3545_CR12","doi-asserted-by":"crossref","first-page":"102374","DOI":"10.1016\/j.jaut.2019.102374","volume":"110","author":"M Aringer","year":"2020","unstructured":"Aringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun. 2020;110:102374.","journal-title":"J Autoimmun"},{"key":"3545_CR13","doi-asserted-by":"crossref","unstructured":"Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. 2010;60(6).","DOI":"10.1016\/j.jinf.2010.03.016"},{"key":"3545_CR14","doi-asserted-by":"crossref","first-page":"102979","DOI":"10.1016\/j.jaut.2022.102979","volume":"137","author":"SL Coss","year":"2023","unstructured":"Coss SL, Zhou D, Chua GT, et al. The complement system and human autoimmune diseases. J Autoimmun. 2023;137:102979.","journal-title":"J Autoimmun"},{"key":"3545_CR15","doi-asserted-by":"crossref","unstructured":"Badagliacca R, Papa S, Rischard F. Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping. J Heart Lung Transpl. 2021;40(2).","DOI":"10.1016\/j.healun.2020.11.001"},{"key":"3545_CR16","doi-asserted-by":"crossref","unstructured":"Hoeper MM, Pausch C, Gr\u00fcnig E et al. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry. J Heart Lung Transpl. 2020;39(12).","DOI":"10.1016\/j.healun.2020.09.011"},{"key":"3545_CR17","unstructured":"Aringer M, Costenbader K, Daikh D et al. 2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9)."},{"key":"3545_CR18","doi-asserted-by":"crossref","unstructured":"Shiboski CH, Shiboski SC, Seror R et al. 2016 American college of rheumatology\/european league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2017;76(1).","DOI":"10.1136\/annrheumdis-2016-210571"},{"key":"3545_CR19","doi-asserted-by":"crossref","unstructured":"van den Hoogen F, Khanna D, Fransen J et al. 2013 Classification criteria for systemic sclerosis: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11).","DOI":"10.1136\/annrheumdis-2013-eular.238"},{"key":"3545_CR20","unstructured":"Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9)."},{"key":"3545_CR21","doi-asserted-by":"crossref","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2).","DOI":"10.1016\/0002-9343(72)90064-2"},{"issue":"3","key":"3545_CR22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.healun.2021.10.018","volume":"41","author":"A Yogeswaran","year":"2022","unstructured":"Yogeswaran A, Tello K, Lund J, et al. Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters. J Heart Lung Transpl. 2022;41(3):400\u201310.","journal-title":"J Heart Lung Transpl"},{"issue":"7","key":"3545_CR23","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","volume":"23","author":"A Buonacera","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23(7):3636.","journal-title":"Int J Mol Sci"},{"key":"3545_CR24","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N, Barber\u00e0 JA, Frost AE et al. Initial use of ambrisentan plus Tadalafil in pulmonary arterial hypertension. N Engl J Med. 2015;373(9).","DOI":"10.1056\/NEJMoa1413687"},{"issue":"12","key":"3545_CR25","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1136\/annrheumdis-2018-214605","volume":"78","author":"J Qian","year":"2019","unstructured":"Qian J, Li M, Zhao J, Wang Q, Tian Z, Zeng X. Inflammation in SLE-PAH: good news or not? Ann Rheum Dis. 2019;78(12):e135.","journal-title":"Ann Rheum Dis"},{"key":"3545_CR26","doi-asserted-by":"crossref","unstructured":"Prisco SZ, Thenappan T, Prins KW. Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension. JACC Basic Transl Sci. 2020;5(12).","DOI":"10.1016\/j.jacbts.2020.07.011"},{"issue":"24","key":"3545_CR27","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1161\/CIRCULATIONAHA.116.022082","volume":"133","author":"S Hsu","year":"2016","unstructured":"Hsu S, Houston BA, Tampakakis E, et al. Right ventricular functional reserve in pulmonary arterial hypertension. Circulation. 2016;133(24):2413\u201322.","journal-title":"Circulation"},{"issue":"3","key":"3545_CR28","doi-asserted-by":"crossref","first-page":"103013","DOI":"10.1016\/j.autrev.2021.103013","volume":"21","author":"P Decker","year":"2022","unstructured":"Decker P, Moulinet T, Pontille F, Cravat M, De Carvalho Bittencourt M, Jaussaud R. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev. 2022;21(3):103013.","journal-title":"Autoimmun Rev"},{"key":"3545_CR29","doi-asserted-by":"crossref","unstructured":"Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro\/SS-A autoantibody system. Autoimmun Rev. 2009;8(7).","DOI":"10.1016\/j.autrev.2009.02.010"},{"key":"3545_CR30","doi-asserted-by":"crossref","unstructured":"Okawa-Takatsuji M, Aotsuka S, Uwatoko S, Takaono M, Iwasaki K, Kinoshita M et al. Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases. Clin Exp Immunol 2001 November;126 (2).","DOI":"10.1046\/j.1365-2249.2001.01669.x"},{"key":"3545_CR31","doi-asserted-by":"crossref","unstructured":"Qu J, Li M, Wang Y et al. Predicting the risk of pulmonary arterial hypertension in systemic lupus erythematosus: A Chinese systemic lupus erythematosus treatment and research group cohort study. Arthritis Rheumatol. 2021;73(10).","DOI":"10.1002\/art.41740"},{"key":"3545_CR32","unstructured":"Hachulla E, Jais X, Cinquetti G et al. Pulmonary arterial hypertension associated with systemic lupus erythematosus: results from the French pulmonary hypertension registry. Chest. 2018;153(1)."},{"issue":"5","key":"3545_CR33","doi-asserted-by":"crossref","first-page":"1902157","DOI":"10.1183\/13993003.02157-2019","volume":"56","author":"J Wang","year":"2020","unstructured":"Wang J, Li M, Wang Q, et al. Pulmonary arterial hypertension associated with primary Sj\u00f6gren\u2019s syndrome: a multicentre cohort study from China. Eur Respir J. 2020;56(5):1902157.","journal-title":"Eur Respir J"},{"key":"3545_CR34","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.","journal-title":"Nat Rev Dis Primers"},{"key":"3545_CR35","doi-asserted-by":"crossref","unstructured":"Sobanski V, Giovannelli J, Lynch BM, Schreiber BE, Nihtyanova SI, Harvey J, Handler CE, Denton CP, Coghlan JG. Characteristics and survival of anti-U1 RNP antibody-Positive patients with connective tissue Disease-Associated pulmonary arterial hypertension. Arthritis Rheumatol 2016;68(2).","DOI":"10.1002\/art.39432"},{"key":"3545_CR36","doi-asserted-by":"crossref","unstructured":"Zhao J, Wang Q, Liu Y et al. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China. Int J Cardiol. 2017;236.","DOI":"10.1016\/j.ijcard.2017.01.097"},{"key":"3545_CR37","doi-asserted-by":"crossref","unstructured":"Chen X, Quan R, Qian Y et al. 10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry. Rheumatology (Oxford). 2023;62(11).","DOI":"10.1093\/rheumatology\/kead103"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03545-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03545-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:42:27Z","timestamp":1743849747000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03545-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3545"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03545-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). This study was approved by the Medical Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (number 2018-SR-333). All prospective participants had given written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}